A- A A+

Australien. The stigma of long-term methadone treatment (Audio)

People in treatment programs for opiates face considerable stigma.

We hear from a woman with lived experience of addiction, treatment and stigma, and an expert on what best practice looks like for opiate treatment in Australia. (ABC radio Network, Australien, 15.08.2022, Audio, 09:45)

https://www.abc.net.au/radionational/programs/healthreport/methadone-stigma/101333374

Frameworks and measures for HIV-related internalized stigma, stigma and discrimination in healthcare and in laws and policies: a systematic review. 

Ferguson L, Gruskin S, Bolshakova M, Yagyu S, Fu N, Cabrera N, Rozelle M, Kasoka K, Oraro-Lawrence T, Stackpool-Moore L, Motala A, Hempel S. 

J Int AIDS Soc. 2022 Jul;25 Suppl 1(Suppl 1):e25915. doi: 10.1002/jia2.25915. PMID: 35818866; PMCID: PMC9274352.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274352/

Does Online Newsmedia Portrayal of Substance Use and Persons with Substance Misuse Endorse Stigma? A Qualitative Study from India. 

Ghosh A, Naskar C, Sharma N, Fazl-E-Roub, Choudhury S, Basu A, Pillai RR, Basu D, Mattoo SK. 

Int J Ment Health Addict. 2022 Jun 24:1-19. doi: 10.1007/s11469-022-00859-1. Epub ahead of print. PMID: 35789814; PMCID: PMC9243953.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243953/

HIV Related Stigma among Healthcare Providers: Opportunities for Education and Training. 

Spence AB, Wang C, Michel K, Ocampo JM, Kharfen M, Merenstein D, Goparaju L, Kassaye S. 

J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221114797. doi: 10.1177/23259582221114797. PMID: 35850610; PMCID: PMC9310064.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310064/

Changes in Attitudes toward People with Substance Use Disorder: A Comparative Study of the General Population in Mexico. 

Bustos-Gamiño M, Mora-Ríos J, Villatoro-Velázquez J, Fleiz-Bautista C, Molina-López A, Medina-Mora ME. 

Int J Environ Res Public Health. 2022 Jul 13;19(14):8538. doi: 10.3390/ijerph19148538. PMID: 35886390; PMCID: PMC9316581.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316581/

Public stigma of opioid addiction: Is opioid use disorder really a medical illness?

Public stigma of opioid addiction can affect opioid use disorder service availability and access, as well as the mental health and well-being of persons with an opioid use disorder. To further understand opportunities to enhance support for an empirically-supported, public health approach to opioid use disorder, this study reports on the public’s attitudes toward opioid addiction in a statewide survey of adults in Pennsylvania. (Recovery Research Institute, USA, Juli 2022)

https://www.recoveryanswers.org/research-post/public-stigma-opioid-addiction-opioid-use-disorder-medical-illness/

"You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids. 

Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. 

Subst Abuse. 2022 Jun 27;16:11782218221103859. doi: 10.1177/11782218221103859. PMID: 35783464; PMCID: PMC9243471.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243471/

Parents of adult children with drug addiction dealing with shame and courtesy stigma

Olivia Liahaugen Flensburg, Torkel Richert & Marie Väfors Fritz (2022)

Drugs: Education, Prevention and Policy, DOI: 10.1080/09687637.2022.2099249

https://www.tandfonline.com/doi/full/10.1080/09687637.2022.2099249

Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot. 

Treloar C, Lancaster K, Gendera S, Rhodes T, Shahbazi J, Byrne M, Degenhardt L, Farrell M. 

Int J Drug Policy. 2022 Jul 8;107:103788. doi: 10.1016/j.drugpo.2022.103788. Epub ahead of print. PMID: 35816790.

https://www.sciencedirect.com/science/article/abs/pii/S0955395922002043

Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey. 

Lin Q, Kolak M, Watts B, Anselin L, Pollack H, Schneider J, Taylor B. 

Soc Sci Med. 2022 Jul;305:115034. doi: 10.1016/j.socscimed.2022.115034. Epub 2022 May 14. PMID: 35636049.

https://www.sciencedirect.com/science/article/pii/S0277953622003409

Language Matters: Is This a Drug Overdose or Drug Poisoning Crisis?

In public policy, language matters. In drug policy, language has always been divisive. Words from “dealer” to “addict” have been used to marginalise, incarcerate, and strip three-dimensional humanity away from people by casting them as two-dimensional villains. (TalkingDrugs, UK, 09.06.2022)

https://www.talkingdrugs.org/is-this-a-drug-overdose-or-drug-poisoning-crisis

Course and Correlates of Stigma in Patients on Opioid Agonist Treatment: A Prospective Study from an Outpatient Treatment Program in India. 

Ghosh A, Roub F, Pillai RR, Mahintamani T, Basu D, Subodh BN, Mattoo SK. 

Indian J Psychol Med. 2022 May;44(3):246-252. doi: 10.1177/02537176211012103. Epub 2021 Jun 14. PMID: 35656428; PMCID: PMC9125463.

https://journals.sagepub.com/doi/10.1177/02537176211012103

Factors influencing medical students' attitudes towards substance use during pregnancy.

Richelle L, Dramaix-Wilmet M, Roland M, Kacenelenbogen N. 

BMC Med Educ. 2022 May 2;22(1):335. doi: 10.1186/s12909-022-03394-8. PMID: 35501752; PMCID: PMC9060417.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060417/

Applicability of a national strategy for patient-oriented research to people who use(d) substances: a Canadian experience. 

Pauly B, Sullivan G, Inglis D, Cameron F, Phillips J, Rosen C, Bullock B, Cartwright J, Hainstock T, Trytten C, Urbanoski K. 

Res Involv Engagem. 2022 May 24;8(1):22. doi: 10.1186/s40900-022-00351-z. PMID: 35610726; PMCID: PMC9127478.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127478/

Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study. 

Smith LR, Shumskaia N, Kurmanalieva A, Patterson TL, Werb D, Blyum A, Algarin AB, Yeager S, Cepeda J. 

Harm Reduct J. 2022 May 25;19(1):53. doi: 10.1186/s12954-022-00633-5. PMID: 35614508; PMCID: PMC9131652.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131652/

A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder. 

Cernasev A, Hohmeier KC, Frederick K, Jasmin H, Gatwood J. 

Explor Res Clin Soc Pharm. 2021 Jun 4;2:100029. doi: 10.1016/j.rcsop.2021.100029. PMID: 35481114; PMCID: PMC9029901.

https://www.sciencedirect.com/science/article/pii/S2667276621000299

USA. The Americans with Disabilities Act and the Opioid Crisis: Combating Discrimination Against People in Treatment or Recovery

The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (ADA), which prohibits discrimination against people in recovery from opioid use disorder (OUD) who are not engaging in illegal drug use, including those who are taking legally-prescribed medication to treat their OUD. This guidance document provides information about how the ADA can protect individuals with OUD from discrimination—an important part of combating the opioid epidemic across American communities. While this document focuses on individuals with OUD, the legal principles discussed also apply to individuals with other types of substance use disorders. (U.S. Department of Justice, Civil Rights Division, 05.04.2022)

https://www.ada.gov/opioid_guidance.pdf

Measuring Stigma Towards People with Opioid Use Problems: Exploratory and Confirmatory Factor Analysis of the Opening Minds Provider Attitudes Towards Opioid-Use Scale (OM-PATOS). 

Knaak S, Patten S, Stuart H. 

Int J Ment Health Addict. 2022 Mar 3:1-12. doi: 10.1007/s11469-022-00788-z. Epub ahead of print. PMID: 35261572; PMCID: PMC8893056.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893056/

Stigmatization of Pregnant Individuals with Opioid Use Disorder. 

Crawford AD, McGlothen-Bell K, Recto P, McGrath JM, Scott L, Brownell EA, Cleveland LM. 

Womens Health Rep (New Rochelle). 2022 Feb 2;3(1):172-179. doi: 10.1089/whr.2021.0112. PMID: 35262054; PMCID: PMC8896218.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896218/

Healthcare Professional Students' Perspectives on Substance Use Disorders and Stigma: A Qualitative Study. 

Cernasev A, Kline KM, Barenie RE, Hohmeier KC, Stewart S, Forrest-Bank SS. 

Int J Environ Res Public Health. 2022 Feb 27;19(5):2776. doi: 10.3390/ijerph19052776. PMID: 35270468; PMCID: PMC8909966.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909966/

Relationship between psychological factors and perceived stigma of addiction among women with substance use disorders, Thailand. 

Yangyuen S, Kanato M, Somdee T. 

J Educ Health Promot. 2022 Jan 31;11:16. doi: 10.4103/jehp.jehp_572_21. PMID: 35281408; PMCID: PMC8893069.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893069/

Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy. 

Cheetham, Ali & Picco, Louisa & Barnett, Tony & Lubman, Dan & Nielsen, Suzanne. (2022). The 

Substance Abuse and Rehabilitation. Volume 13. 1-12. 10.2147/SAR.S304566.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800858/

Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia-A prospective cohort analysis. 

Vetrova M, Lodi S, Rateau L, Patts G, Blokhina E, Palatkin V, Yaroslavtseva T, Toussova O, Bushara N, Bendiks S, Gnatienko N, Krupitsky E, Lioznov D, Samet JH, Lunze K. 

Int J Drug Policy. 2022 Feb 5;102:103600. doi: 10.1016/j.drugpo.2022.103600. Epub ahead of print. PMID: 35134598.

https://www.sciencedirect.com/science/article/pii/S0955395922000202

Stigma reduction is key to improving the HIV care continuum

Poteat, Tonia C et al.

The Lancet HIV, Volume 9, Issue 3, e144 - e145 

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00323-4/fulltext

Global assessment of existing HIV and key population stigma indicators: A data mapping exercise to inform country-level stigma measurement. 

Lyons C, Bendaud V, Bourey C, Erkkola T, Ravichandran I, Syarif O, et al. (2022) 

PLoS Med 19(2): e1003914. doi.org/10.1371/journal.pmed.1003914

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003914

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy. 

Cheetham A, Picco L, Barnett A, Lubman DI, Nielsen S. 

Subst Abuse Rehabil. 2022 Jan 25;13:1-12. doi: 10.2147/SAR.S304566. PMID: 35115860; PMCID: PMC8800858.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800858/

Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population. 

Bascou NA, Haslund-Gourley B, Amber-Monta K, Samson K, Goss N, Meredith D, Friedman A, Needleman A, Kumar VK, Fischer BD. 

Harm Reduct J. 2022 Jan 16;19(1):5. doi: 10.1186/s12954-022-00589-6. PMID: 35034649; PMCID: PMC8761384.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761384/

Exploring stigma associated with mental health conditions and alcohol and other drug use among people from migrant and ethnic minority backgrounds: a protocol for a systematic review of qualitative studies. 

Douglass CH, Lim MSC, Block K, Onsando G, Hellard M, Higgs P, Livingstone C, Horyniak D.

Syst Rev. 2022 Jan 18;11(1):12. doi: 10.1186/s13643-021-01875-3. PMID: 35042545; PMCID: PMC8767730.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767730/

Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies. 

Reynolds G, Lindsay BL, Knaak S, Szeto ACH. 

Int J Ment Health Addict. 2022 Jan 20:1-17. doi: 10.1007/s11469-022-00756-7. Epub ahead of print. PMID: 35079240; PMCID: PMC8773394.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773394/

Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Care Professionals: A Randomized Clinical Trial. 

Kennedy-Hendricks A, McGinty EE, Summers A, Krenn S, Fingerhood MI, Barry CL. 

JAMA Netw Open. 2022 Feb 1;5(2):e2146971. doi: 10.1001/jamanetworkopen.2021.46971. PMID: 35119460.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788642